drugset / Trial / NCT00446771
A Pharmacokinetic and Bioavailability Study of Mannitol for Inhalation Using Normal Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
The study has an open-label, randomized, crossover design, in which each subject will receive mannitol powder for inhalation using a dry powder inhaler with and without premedication with a bronchodilator, mannitol powder for inhalation in capsules administered orally, and mannitol in a commercial formulation designed for intravenous use.
Timeline
- Start
- 2006-10
- Primary completion
- —
- Completion
- 2006-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mannitol | Diagnostic / imaging agent | — | Inhaled |
Indications
No indication recorded.